Skip to main content
logo
IDNA Genomics Public Ltd (CYS:IDNA)
Cyprus flag Cyprus · Delayed Price · Currency is EUR
21.00
-1.80 (-7.89%)
At close: May 29, 2026

IDNA Genomics Public Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
0.490.490.480.49
Revenue Growth
2.95%2.95%-3.01%-
Gross Profit
-0.13-0.130.130.32
Operating Income
-3.24-3.24-1.48-1.2
Net Income
-2.24-2.24-2.52-1.34
Earnings Per Share
-0.81-0.81-0.91-0.49
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
0.010.010.410.1
Total Debt
2.922.922.713.15
Net Cash (Debt)
-2.91-2.91-2.31-3.05
Net Cash Growth
----
Net Cash Per Share
-1.05-1.05-0.84-1.10

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-0.25-0.25-2.52-0.01
Capital Expenditures
-0-0-0.01-0
Free Cash Flow
-0.25-0.25-2.53-0.01
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
-26.36%-26.36%27.22%65.56%
Operating Margin
-658.70%-658.70%-309.19%-244.23%
Pretax Margin
-698.45%-698.45%-620.21%-271.64%
Profit Margin
-454.68%-454.68%-527.75%-272.77%
FCF Margin
-50.83%-50.83%-528.51%-2.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
117.76185.05159.33154.54